Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Green Cross Holdings Corp. (005250:KRX), powered by AI.
Green Cross Holdings Corp. is currently trading at ₩11,730. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Green Cross Holdings Corp. on Alpha Lenz.
Green Cross Holdings Corp.'s P/E ratio is -7.9.
“Green Cross Holdings Corp. trades at a P/E of -7.9 (undervalued) with modest ROE of -7.3%.”
Ask for details →Green Cross Holdings Corp. is a prominent corporation in the healthcare and pharmaceuticals sector, primarily focusing on the development, manufacturing, and distribution of biotechnical products. This company is renowned for its innovative contribution to the biotechnology space, particularly in the production of vaccines, blood derivatives, and other healthcare solutions designed to improve global health standards. Green Cross Holdings Corp. plays a vital role in the pharmaceutical industry by advancing research on essential vaccines and therapeutic solutions, which are pivotal in addressing numerous medical challenges. The company's influence extends across global healthcare markets, with its products and solutions facilitating enhanced disease prevention and treatment capabilities. Based in South Korea, Green Cross Holdings Corp. remains a critical player in the ongoing efforts to promote health and wellness worldwide, leveraging its expertise to meet the growing demands of modern medicine and public health initiatives.
“Green Cross Holdings Corp. trades at a P/E of -7.9 (undervalued) with modest ROE of -7.3%.”
Ask for details →Green Cross Holdings Corp. (ticker: 005250) is a company listed on KRX in the Healthcare sector (Biotechnology). It has approximately 141 employees. Market cap is $551.6B.
The current price is ₩11,730 with a P/E ratio of -7.94x and P/B of 0.61x.
ROE is -7.34% and operating margin is 1.49%. Annual revenue is $2.5T.